The Clorox Company (NYSE:CLX) Stock Holdings Lessened by Parsifal Capital Management LP

Parsifal Capital Management LP cut its holdings in The Clorox Company (NYSE:CLX - Free Report) by 25.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 693,788 shares of the company's stock after selling 236,071 shares during the quarter. Clorox comprises 7.7% of Parsifal Capital Management LP's holdings, making the stock its 5th biggest position. Parsifal Capital Management LP owned approximately 0.56% of Clorox worth $113,025,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CLX. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the 3rd quarter valued at approximately $27,000. Innealta Capital LLC acquired a new position in Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC boosted its position in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after acquiring an additional 130 shares during the last quarter. Family Firm Inc. acquired a new position in Clorox during the 2nd quarter worth approximately $31,000. Finally, Quarry LP boosted its position in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on CLX shares. JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research report on Friday, October 11th. DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research report on Monday, November 4th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and upped their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and increased their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, Evercore ISI dropped their price target on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $155.00.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

Clorox Trading Up 0.2 %

Shares of CLX stock traded up $0.40 during mid-day trading on Wednesday, reaching $167.53. 827,086 shares of the stock traded hands, compared to its average volume of 1,234,611. The stock's fifty day simple moving average is $163.18 and its two-hundred day simple moving average is $149.90. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35. The company has a market cap of $20.74 billion, a price-to-earnings ratio of 58.21, a price-to-earnings-growth ratio of 3.08 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the company earned $0.49 earnings per share. The firm's revenue was up 27.0% compared to the same quarter last year. On average, research analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.91%. Clorox's payout ratio is currently 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.